Deucravacitinib is a unique oral medication that treats autoimmune illnesses, including psoriasis. As a selective TYK2 inhibitor, it controls the immune system while limiting negative effects. Pharmaffiliates offers deuterated Deucravacitinib (CAS No: 1609392-27-9) which is used by researchers to study mechanism of action, reaction processes, and pharmacological pathway. Our products and services aim to support healthcare professionals and researchers in understanding this cutting-edge treatment better. Stay updated with Pharmaffiliates to explore our latest compounds and services.